Literature DB >> 24252114

Rescuing biological activity from synthetic phakellistatin 19.

Marta Pelay-Gimeno1, Alessandra Meli, Judit Tulla-Puche, Fernando Albericio.   

Abstract

Phakellistatins is one of the families of Pro-rich cyclic peptides whose synthetic counterparts have revealed cytotoxicities that differ greatly from those displayed by their corresponding natural ones. This is also the case of the last member isolated from this family, phakellistatin19, an octacyclopeptide containing three Pro moieties and a high percentage of apolar residues. Exhaustive NMR studies on the synthetic and natural phakellistatin 19 have been performed in order to find a plausible explanation for this intriguing behavior. Moreover, taking advantage of phakellistatin's framework, analogues with different cis/trans geometry at the key prolyl peptide bonds were designed, covering a promising conformational space that could not be reached by the natural peptide. By introduction of proline surrogates (Ψ(Me,Me)pro residues) in phakellistatin 19, which effectively increases the percentage of cis conformation in the final peptides, this translates into enhanced biological activity, therefore "rescuing" an otherwise inactive cyclopeptide.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24252114     DOI: 10.1021/jm401520x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

2.  Cysteine pseudoprolines for thiol protection and peptide macrocyclization enhancement in Fmoc-based solid-phase peptide synthesis.

Authors:  Tobias M Postma; Fernando Albericio
Journal:  Org Lett       Date:  2014-03-11       Impact factor: 6.005

Review 3.  Phakellistatins: An Underwater Unsolved Puzzle.

Authors:  Alessandra Meli; Consiglia Tedesco; Giorgio Della Sala; Rosaria Schettini; Fernando Albericio; Francesco De Riccardis; Irene Izzo
Journal:  Mar Drugs       Date:  2017-03-18       Impact factor: 5.118

Review 4.  Bioactive Peptide of Marine Origin for the Prevention and Treatment of Non-Communicable Diseases.

Authors:  Ratih Pangestuti; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2017-03-09       Impact factor: 5.118

5.  Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.

Authors:  Rachael Dickman; Serena A Mitchell; Angelo M Figueiredo; D Flemming Hansen; Alethea B Tabor
Journal:  J Org Chem       Date:  2019-08-29       Impact factor: 4.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.